Biggest News Aggregation in the World
📰 Dave Fredrickson News

Page 7 - Dave Fredrickson News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dave Fredrickson. Real-time updates on events, politics, business and more.

FDA Approves LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone for Treatment of Adult Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)

LYNPARZA combination showed a clinically meaningful reduction in risk of disease progression or death in these patients in the Phase 3 PROpel trial First approval of a PARP inhibitor in combination... | June 1, 2023
United States Dave Fredrickson Eliav Barr Andrew Armstrong Drug Administration Merck Co Inc

LYNPARZA® (olaparib) plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer

LYNPARZA combination reduced the risk of disease progression or death by 76% vs. abiraterone alone First PARP inhibitor approved in combination with a novel hormonal agent underscores clinically... | June 1, 2023
United Kingdom North Carolina United States Comunidad Autonoma De Cataluna Dave Fredrickson Eliav Barr

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

FDA Approves Olaparib Plus Abiraterone, Prednisone for Metastatic Castration-Resistant Prostate Cancer

Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.
United States Andrew Armstrong Dave Fredrickson Eliav Barr Merck Research Laboratories Adobe Stock

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science